Valuation : aap Implantate AG

Market Cap 20.45M 23.75M 19.2M 17.53M 32.92M 2.26B 33.16M 228M 88.52M 1.15B 89.17M 87.23M 3.79B P/E 2024
-3.6x
P/E 2025 -7.58x
Enterprise Value 20.13M 23.38M 18.9M 17.26M 32.42M 2.22B 32.65M 224M 87.16M 1.13B 87.8M 85.89M 3.74B EV / Sales 2024
1.32x
EV / Sales 2025 1.56x
Free-Float
38.19%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 64 2019-04-30
Director of Finance/CFO - 2026-08-18
Chief Operating Officer - 2026-08-18
Director TitleAgeSince
Director/Board Member 70 2015-12-31
Chairman 55 2019-07-03
Director/Board Member 50 2021-10-31
Change 5-day change 1-year change 3-year change Capi.($)
-9.59%-5.71% - - 23.75M
+0.80%-5.41%-16.81%+7.25% 191B
+2.44%-2.42%-2.33%+11.23% 116B
+1.88%-0.05%+10.97%+83.88% 61.75B
+1.20%-1.38%-2.52%-32.69% 51.24B
+1.18%-0.02%+29.20%+54.07% 51.51B
+0.21%0.00%+22.56%-9.82% 34.36B
+2.20%+0.95% - - 30.73B
-0.77%-3.46%+38.13%-16.17% 24.01B
+1.13%-1.96%-5.16%+15.32% 23.23B
Average +0.09%-1.41%+9.25%+14.13% 64.87B
Weighted average by Cap. +1.35%-1.93%+0.26%+15.56%

Financials

2024 2025
Net sales 12.2M 14.17M 11.46M 10.46M 19.65M 1.35B 19.79M 136M 52.83M 684M 53.22M 52.06M 2.26B 12.49M 14.5M 11.72M 10.7M 20.11M 1.38B 20.25M 139M 54.06M 700M 54.45M 53.27M 2.32B
Net income -3.63M -4.22M -3.41M -3.11M -5.84M -401M -5.89M -40.39M -15.71M -203M -15.83M -15.49M -674M -2.58M -3M -2.43M -2.22M -4.16M -286M -4.19M -28.76M -11.19M -145M -11.27M -11.03M -480M
Net Debt -1.1M -1.28M -1.03M -944K -1.77M -122M -1.79M -12.25M -4.77M -61.7M -4.8M -4.7M -204M -314K -365K -295K -269K -506K -34.7M -509K -3.49M -1.36M -17.6M -1.37M -1.34M -58.26M
Logo aap Implantate AG
aap Implantate AG is a Germany-based provider of medical devices for human muscular and skeletal systems. The Company focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . It also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The Company operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.
Employees
-